TY  - GEN
AU  - Hashemi Sadraei,Nooshin
AU  - Feng,Yan
AU  - Du,Lingling
AU  - Fu,Pingfu
AU  - Haque,Sulsal
AU  - Dowlati,Afshin
AU  - Gollamudi,Jahnavi
AU  - Pennell,Nathan A
AU  - Mekhail,Tarek
AU  - Avril,Stefanie
AU  - Farver,Carol
AU  - Gerson,Stanton L
AU  - Sharma,Neelesh
TI  - High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer
SN  - 1872-8332
PY  - 2019///0930
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - BRCA1 Protein
KW  - biosynthesis
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Carcinoma, Non-Small-Cell Lung
KW  - diagnosis
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Pemetrexed
KW  - administration & dosage
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Uracil-DNA Glycosidase
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.lungcan.2018.08.011
ER  -